- Home
- Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease
Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
- $ 3 500
- Industry report
- by GBI Research
- May 2012
- 129 pages
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business intelligence provider, has released its latest research ?Generics in Cardiovascular Diseases ...
Industries: Pathology | Countries: World
Pathology in United States: Vertex Pharmaceuticals Incorporated - Product Pipeline Review - H2 2011
- $ 500
- Company report
- by Global Markets Direct
- May 2012
- 139 pages
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Vertex Pharmaceuticals Incorporated's corporate website, ...
Industries: Pathology
Nutrition 21, Inc.: Ingredients Company Profile, SWOT & Financial Report
- $ 125
- Company report
- by Canadean Ltd
- May 2012
- 30 pages
Product Synopsis Canadean's "Nutrition 21, Inc.: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, mergers & acquisitions, ...
Industries: Pathology | Countries: United States
Autoimmune Disease Therapeutics to 2016
- $ 3 850
- Industry report
- by Greystone Research Associates
- May 2012
As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until ...
Industries: Pathology
Bladder Cancer Partnering 2007-2012
- $ 995
- Industry report
- by Currentpartnering
- May 2012
- 150 pages
Summary The Bladder Cancer Partnering 2007-2012 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bladder cancer partnering deals Top bladder cancer deals by value Deals listed by company A-Z, ...
Industries: Pathology
Brain Cancer Partnering 2007-2012
- $ 995
- Industry report
- by Currentpartnering
- May 2012
- 150 pages
Summary The Brain Cancer Partnering 2007-2012 report provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in brain cancer partnering deals Top brain cancer deals by value Deals listed by company A-Z, industry ...
Industries: Pathology
Breast Cancer Partnering 2007-2012
- $ 1 695
- Industry report
- by Currentpartnering
- May 2012
- 250 pages
Summary The Breast Cancer Partnering 2007-2012 report provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in breast cancer partnering deals Top breast cancer deals by value Deals listed by company A-Z, ...
Industries: Pathology
Cervical Cancer Partnering 2007-2012
- $ 995
- Industry report
- by Currentpartnering
- May 2012
- 150 pages
Summary The Cervical Cancer Partnering 2007-2012 report provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cervical cancer partnering deals Top cervical cancer deals by value Deals listed by company ...
Industries: Pathology
Colorectal Cancer Partnering 2007-2012
- $ 995
- Industry report
- by Currentpartnering
- May 2012
- 200 pages
Summary The Colorectal Cancer Partnering 2007-2012 report provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in colorectal cancer partnering deals Top colorectal cancer deals by value Deals listed ...
Industries: Pathology
Gastric Cancer Partnering 2007-2012
- $ 995
- Industry report
- by Currentpartnering
- May 2012
- 150 pages
Summary The Gastric Cancer Partnering 2007-2012 report provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastric cancer partnering deals Top gastric cancer deals by value Deals listed by company A-Z, ...
Industries: Pathology
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
Reportlinker.com © Copyright 2012. All rights reserved
